Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immuno-Deficiency”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Post-approval studies (Phase 4)Ended earlyNCT00356616
What this trial is testing

Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 24
Not applicableLooking for participantsNCT05973825
What this trial is testing

Immuno-virological Evaluation of Persons Living With HIV (PLWH)

Who this might be right for
HIV-1-infectionHIV Seropositivity
University Hospital, Ghent 24
Large-scale testing (Phase 3)Study completedNCT02075593
What this trial is testing

ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV InfectionsArthralgia
ViiV Healthcare 4
Testing effectiveness (Phase 2)Temporarily pausedNCT03312244
What this trial is testing

Pyridostigmine as Immunomodulator in People Living With HIV

Who this might be right for
HIV-1-infectionCD4+ T LymphocytopeniaImmune Deficiency+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 60
Large-scale testing (Phase 3)Active Not RecruitingNCT02997228
What this trial is testing

Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study

Who this might be right for
Metastatic Colorectal AdenocarcinomaStage IV Colorectal Cancer AJCC v7
National Cancer Institute (NCI) 120
Large-scale testing (Phase 3)Looking for participantsNCT06279130
What this trial is testing

Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations

Who this might be right for
Resectable MMR-deficient Solid TumorsResectable MMR-proficient Solid Tumors
The Netherlands Cancer Institute 133
Very early researchLooking for participantsNCT06787560
What this trial is testing

CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases

Who this might be right for
Bone Marrow Failure Syndrome
Zhejiang University 20
Not applicableNot Yet RecruitingNCT07691424
What this trial is testing

Impact of Migration History and Social Conditions on the Immuno-virological Control of HIV in Migrants in France

Who this might be right for
HIV - Human Immunodeficiency VirusSocio-economic StatusMigrants
University Hospital, Clermont-Ferrand 150
Not applicableLooking for participantsNCT00001778
What this trial is testing

Evaluation of Patients With HAM/TSP

Who this might be right for
HTLV-I InfectionTropical Spastic Paraparesis
National Institute of Neurological Disorders and Stroke (NINDS) 750
Not applicableStudy completedNCT03166449
What this trial is testing

Effects of Immunonutrition on Biomarkers in Traumatic Brain Injury

Who this might be right for
Traumatic Brain InjuryImmuno-DeficiencyNutrient Deficiency
University of Malaya 36
Testing effectiveness (Phase 2)Ended earlyNCT06032546
What this trial is testing

Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382

Who this might be right for
Human Immuno-deficiency Virus (HIV) Disease
AbbVie 163
Large-scale testing (Phase 3)Study completedNCT04738812
What this trial is testing

Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression

Who this might be right for
TuberculosisHIV-1-infectionImmuno-Deficiency
ANRS, Emerging Infectious Diseases 1,330
Not applicableStudy completedNCT05461378
What this trial is testing

PREP (Pre-Exposure Prophylaxis) of COVID-19

Who this might be right for
Immuno-DeficiencyCOVID-19
Ghady Haidar 138
Early research (Phase 1)UnknownNCT00858923
What this trial is testing

Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV)

Who this might be right for
HIVHIV Infections
Energex Systems, Inc. 10
Early research (Phase 1)Study completedNCT00000822
What this trial is testing

A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 46
Not applicableUnknownNCT05278559
What this trial is testing

Can Undetectable (Viral Load) = Untransmissible (Virus) Change the Life Course of Adolescents Living in Africa

Who this might be right for
HIV/AIDS
Centre for Sexual Health and HIV/AIDS Research Zimbabwe 300
Large-scale testing (Phase 3)UnknownNCT04836260
What this trial is testing

Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19

Who this might be right for
Covid19Immuno-DeficiencyOld Age; Debility
University Hospital, Geneva 100
Large-scale testing (Phase 3)Study completedNCT01348308
What this trial is testing

Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients

Who this might be right for
HIV-1 InfectionAIDS
ANRS, Emerging Infectious Diseases 407
Early research (Phase 1)Study completedNCT00000633
What this trial is testing

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Testing effectiveness (Phase 2)Study completedNCT02315703
What this trial is testing

Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 393
Next Page